TaiAx Capital L.P. is a venture capital firm established in 2024 as a joint venture between Taiwan-based Taiwania Capital Management and Tokyo-based Axil Capital Group. The firm invests in biotechnology and healthcare companies, managing the TaiAx Life Science Fund to support innovative life-science technologies.
Focus Areas
Notable Investments
